News

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...
Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...
The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...
For Rogulja, an associate professor of neurobiology in the Blavatnik Institute at Harvard Medical School, an intriguing aspect of sleep is the loss of consciousness and awareness it brings, as the ...
This article is part of Harvard Medical School’s continuing coverage of COVID-19. A new study of more than 800,000 people has found that in the U.S., COVID “long haulers” were more likely to be older ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...
Lesbian, gay, bisexual, transgender, queer, and other sexual and gender minority people (LGBTQ+), are at greater risk of dying by suicide, of cardiovascular disease, and of a cascading list of other ...
At a glance: New AI tool accurately predicts both overall survival and disease-free survival after colorectal cancer diagnosis. The model uses visual markers on pathology images to glean insights into ...
What Will It Take to End Tuberculosis? A boundary-pushing global collaboration is betting on the power of science ...
At a glance: Immunotherapy has redefined cancer treatment, but not all patients experience the same benefit when treated. New research in mice identifies how gut bacteria alter the body’s response to ...
A Mammoth Solution Scientists look to extinct genes to protect endangered species, climate ...
For decades, the military has used autonomous weapons such as mines, torpedoes, and heat-guided missiles that operate based on simple reactive feedback without human control. However, artificial ...